Understanding Control Measures in Pharmaceutical Manufacturing

The Control Measures section of a pharmaceutical quality system (per ICH Q10, EU GMP, FDA cGMP) encompasses the operational controls ensuring product identity, strength, quality, purity, and data integrity throughout the lifecycle.

Core Elements

• Access, Distribution, Inventory, Destruction: Controlled substance accountability, chain of custody, reconciliation, secure disposal (witnessed, documented).
• Physical Security: Restricted access to manufacturing, storage, labs; CCTV, badge readers, visitor logs; protection against theft, tampering, counterfeiting.
• Packaging Controls: Line clearance, label verification (automated), reconciliation of components, tamper-evidence, serialization/track-and-trace.
• Labeling Controls: Design review, proofreading, version control, storage segregation, reconciliation, destruction of obsolete.
• Equipment & Facility Cleaning: Validated cleaning procedures, hold times, swab/rinse sampling, acceptance criteria, cross-contamination prevention, cleaning logs.
• Laboratory Controls: Method validation, stability programs, reference standards, reagent qualification, OOS/OOT investigations, data integrity (ALCOA+).
• Computerized & Automated Systems: 21 CFR Part 11 / Annex 11 compliance: audit trails, access controls, electronic signatures, validation (CSV), backup/recovery, cybersecurity.
• Data Integrity: ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available) across paper and electronic.
• Quality Audits: Internal (self-inspection), external (supplier, contract giver/acceptor), regulatory; CAPA tracking, trending, metrics.

Integration

These controls are embedded in the Pharmaceutical Quality System (PQS) and linked to Change Management, CAPA, Risk Management (ICH Q9), and Knowledge Management (ICH Q10). They ensure consistent GMP compliance and product reliability.